CordenPharma Acquires Ancora Pharmaceuticals' Technology

13-11-2013 Business Wire HealthComments (0)


CordenPharma acquires Ancora Pharmaceuticals' unique carbohydrate synthesis technology platform to join CordenPharma's commercial-scale cGMP carbohydrate manufacturing capabilities.

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top